The Department of Veterans Affairs is seeking experienced contractors for a potential five-year IDIQ contract to supply PET MRI Radiopharmaceuticals to the John D. Dingell VA Medical Center in Detroit, Michigan. The goal is to ensure a steady supply of these specialized pharmaceuticals to enhance the center's medical capabilities.
This sources sought notice is issued for market research purposes to gauge interest and capability in meeting the VA Medical Center's requirements. The center requires a reliable supply of a range of PET radiopharmaceuticals, including Cu64 Dotatate, F18 PSMA, F18 FDG, and F18 Vizamyl, for medical purposes.
The selected contractor will be responsible for fulfilling orders of these pharmaceuticals, ensuring timely deliveries, and adhering to strict quality control measures. They must employ registered radio-pharmacists and provide a trouble-shooter to assist with any issues. Additionally, the contractor must manage waste products disposal and comply with regulations regarding shipping and handling.
This opportunity is open to businesses capable of meeting the stringent requirements for handling and supplying these specialized pharmaceuticals. Registration in the System for Award Management (SAM) is mandatory. Contractors claiming small business preferences must meet relevant FAR guidelines and register with the SBA.
Funding for this contract is estimated at approximately $1.5 million over the five-year period. The contract type is an IDIQ contract with a potential ordering period from October 1, 2024, to September 30, 2029.
Interested parties should provide a response to the Contracting Officer, Jeffrey Rozema, via email by the deadline. The email should include:
- Business Name and Address
- Point of Contact Details
- SAM Unique Entity ID
- Type of Small Business, if applicable
- A detailed description of the company's ability to meet the requirements, including facility locations and relevant experience.
Responses will be evaluated based on the extent to which they demonstrate an ability to meet the stated requirements. The VA will select vendors capable of providing a reliable supply of the required pharmaceuticals under the specified conditions.
For clarification or further information, interested parties can contact Jeffrey Rozema, Contracting Officer, via email at jeffrey.rozema@va.gov or by phone at 269-966-5600 ext. 36450.
The government encourages interested parties to respond, as this is a sources sought notice to gauge interest and capability.